Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients

NCT00329485 ·Status: TERMINATED ·Phase: NA

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

NCT00259038 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

NCT01055912 ·Status: COMPLETED ·Phase: PHASE2

Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction

NCT05477498 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction

NCT03281122 ·Status: TERMINATED ·Phase: PHASE1

Dapagliflozin in PRESERVED Ejection Fraction Heart Failure

NCT03030235 ·Status: COMPLETED ·Phase: PHASE4

Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency

NCT03344523 ·Status: UNKNOWN ·Phase: PHASE4

The Effects of Ambrisentan on Exercise Capacity in Fontan Patients

NCT01971580 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

NCT01798745 ·Status: WITHDRAWN ·Phase: PHASE2

The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

NCT01505179 ·Status: COMPLETED ·Phase: NA

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

NCT06111768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF

NCT02808585 ·Status: COMPLETED ·Phase: PHASE2

Peroral Levosimendan in Chronic Heart Failure

NCT00130884 ·Status: COMPLETED ·Phase: PHASE2

Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF

NCT04197635 ·Status: COMPLETED ·Phase: PHASE4

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

NCT00043758 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)

NCT01337349 ·Status: WITHDRAWN ·Phase: NA

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)

NCT01481402 ·Status: COMPLETED ·Phase: NA

CD-NP in Subjects With Stable Chronic Heart Failure

NCT00620308 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction

NCT04840914 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT05636176 ·Status: RECRUITING ·Phase: PHASE3

Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)

NCT01546532 ·Status: COMPLETED ·Phase: PHASE2

Study of Dapansutrile Capsules in Heart Failure

NCT03534297 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

NCT05045274 ·Status: UNKNOWN ·Phase: NA

Pilot Study of COR-1 in Heart Failure

NCT01391507 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

NCT00219388 ·Status: COMPLETED ·Phase: PHASE4